165 related articles for article (PubMed ID: 37605344)
21. Trends in incidence, therapy and outcome of localized nodal and extranodal marginal zone lymphomas: declining incidence and inferior outcome for gastrointestinal sites.
Kuper-Hommel MJ; van de Schans SA; Vreugdenhil G; van Krieken JH; Coebergh JW
Leuk Lymphoma; 2013 Sep; 54(9):1891-7. PubMed ID: 23302044
[TBL] [Abstract][Full Text] [Related]
22. MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma.
Martinez-Lopez A; Curiel-Olmo S; Mollejo M; Cereceda L; Martinez N; Montes-Moreno S; Almaraz C; Revert JB; Piris MA
Am J Surg Pathol; 2015 May; 39(5):644-51. PubMed ID: 25723115
[TBL] [Abstract][Full Text] [Related]
23. Discriminating between Waldenström macroglobulinemia and marginal zone lymphoma using logistic LASSO regression.
Amaador K; Vos JMI; Pals ST; Kraan W; Dobber JA; Minnema MC; Koene HR; de Bruin PC; Zwinderman AH; Kersten MJ
Leuk Lymphoma; 2022 May; 63(5):1070-1079. PubMed ID: 34961399
[TBL] [Abstract][Full Text] [Related]
24. Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphoma.
Metcalf RA; Monabati A; Vyas M; Roncador G; Gualco G; Bacchi CE; Younes SF; Natkunam Y; Freud AG
Hum Pathol; 2014 Aug; 45(8):1730-6. PubMed ID: 24925224
[TBL] [Abstract][Full Text] [Related]
25. Floral leukemic cells transformed from marginal zone lymphoma.
Chang ST; Hsieh YC; Lu YH; Tzeng CC; Lin CN; Chuang SS
Pathol Res Pract; 2008; 204(1):23-6. PubMed ID: 17913385
[TBL] [Abstract][Full Text] [Related]
26. Study of the Utility of Myeloid Cell Nuclear Differentiation Antigen (MNDA) in the Diagnosis of Marginal Zone Lymphoma.
Gupta N; Roychoudry S; Sticco KL; Hsu P; Zhang X; Sheikh-Fayyaz S
Appl Immunohistochem Mol Morphol; 2023 Apr; 31(4):217-223. PubMed ID: 36867739
[TBL] [Abstract][Full Text] [Related]
27. MALT Lymphomas.
Cavalli F; Isaacson PG; Gascoyne RD; Zucca E
Hematology Am Soc Hematol Educ Program; 2001; ():241-58. PubMed ID: 11722987
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic features of Waldenstrom's macroglobulinemia and marginal zone lymphoma: are they distinct or the same entity?
Berger F; Traverse-Glehen A; Felman P; Callet-Bauchu E; Baseggio L; Gazzo S; Thieblemont C; Ffrench M; Magaud JP; Salles G; Coiffer B
Clin Lymphoma; 2005 Mar; 5(4):220-4. PubMed ID: 15794852
[TBL] [Abstract][Full Text] [Related]
29. Follicular lymphoma and marginal zone lymphoma: how many diseases?
Laurent C; Cook JR; Yoshino T; Quintanilla-Martinez L; Jaffe ES
Virchows Arch; 2023 Jan; 482(1):149-162. PubMed ID: 36394631
[TBL] [Abstract][Full Text] [Related]
30. Marginal zone lymphoma in elderly and geriatric patients.
Goede V
Best Pract Res Clin Haematol; 2017; 30(1-2):158-165. PubMed ID: 28288711
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary marginal zone B-cell lymphoma of MALT type--what is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) study.
Oh SY; Kim WS; Kim JS; Kim SJ; Kwon HC; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Chae YS; Yang DH; Lee GW; Choi CW; Park J; Suh C; Kim HJ
Ann Hematol; 2010 Jun; 89(6):563-8. PubMed ID: 20024551
[TBL] [Abstract][Full Text] [Related]
32. Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Zucca E; Arcaini L; Buske C; Johnson PW; Ponzoni M; Raderer M; Ricardi U; Salar A; Stamatopoulos K; Thieblemont C; Wotherspoon A; Ladetto M;
Ann Oncol; 2020 Jan; 31(1):17-29. PubMed ID: 31912792
[No Abstract] [Full Text] [Related]
33. Marginal zone B-cell lymphoma: lessons from Western and Eastern diagnostic approaches.
Nakamura S; Ponzoni M
Pathology; 2020 Jan; 52(1):15-29. PubMed ID: 31757436
[TBL] [Abstract][Full Text] [Related]
34. Exclusive detection of the t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas.
Rosenwald A; Ott G; Stilgenbauer S; Kalla J; Bredt M; Katzenberger T; Greiner A; Ott MM; Gawin B; Döhner H; Müller-Hermelink HK
Am J Pathol; 1999 Dec; 155(6):1817-21. PubMed ID: 10595910
[TBL] [Abstract][Full Text] [Related]
35. Splenic marginal-zone lymphoma: a distinct clinical and pathological entity.
Thieblemont C; Felman P; Callet-Bauchu E; Traverse-Glehen A; Salles G; Berger F; Coiffier B
Lancet Oncol; 2003 Feb; 4(2):95-103. PubMed ID: 12573351
[TBL] [Abstract][Full Text] [Related]
36. Nodal marginal zone B-cell lymphoma: a diagnostic and therapeutic dilemma.
Traverse-Glehen A; Bertoni F; Thieblemont C; Zucca E; Coiffier B; Berger F; Salles G
Oncology (Williston Park); 2012 Jan; 26(1):92-9, 103-4. PubMed ID: 22393802
[TBL] [Abstract][Full Text] [Related]
37. Marginal-zone lymphoma.
Ferreri AJ; Zucca E
Crit Rev Oncol Hematol; 2007 Sep; 63(3):245-56. PubMed ID: 17583528
[TBL] [Abstract][Full Text] [Related]
38. Marginal zone lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance.
Lasica M; Anderson MA; Boussioutas A; Gregory GP; Hamad N; Manos K; McKelvie P; Ng M; Campbell B; Palfreyman E; Salvaris R; Weinkove R; Wight J; Opat S; Tam C
Intern Med J; 2024 Jun; 54(6):1017-1030. PubMed ID: 38881453
[TBL] [Abstract][Full Text] [Related]
39. Childhood nodal marginal zone lymphoma with unusual clinicopathologic and cytogenetic features for the pediatric variant: a case report.
Aqil B; Merritt BY; Elghetany MT; Kamdar KY; Lu XY; Curry CV
Pediatr Dev Pathol; 2015; 18(2):167-71. PubMed ID: 25625642
[TBL] [Abstract][Full Text] [Related]
40. Management of marginal zone lymphomas.
Thieblemont C; Coiffier B
Curr Treat Options Oncol; 2006 May; 7(3):213-22. PubMed ID: 16615877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
